TRENDING NOW

UAE GDP projected to rise 5 percent…

Developing Asia-Pacific economy set to grow 5%…

Abdullah bin Zayed joins Trump talks with…

Egypt remittance inflows reach $29.7 billion by…

China holds 3% one-year LPR and 3.5%…

Typhoon Dujuan hits eastern Japan with heavy…

Gene could raise lung cancer risk 60…

Nepal floods leave 6,150 missing after nationwide…

DR Congo Ebola outbreak shows progress amid…

Gold prices decline on Federal Reserve rate…

Tag : Johnson & Johnson

FDA approves Johnson & Johnson’s Spravato for standalone depression treatment
Health

FDA approves Johnson & Johnson’s Spravato for standalone depression treatment

manamalive.com
by manamalive.com0287
The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson’s nasal spray, Spravato, as a standalone treatment for adults with major depressive disorder (MDD) that is resistant to conventional therapies. This marks a...